DNLI Stock Ownership Activity

DENALI THERAPEUTICS INC 13F holders

1 value investing guru has made changes to the DENALI THERAPEUTICS INC (DNLI) position according to the gurus' latest SEC quarterly report(s). The number of DNLI shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying DNLI now?

According to the latest SEC filing(s) DENALI THERAPEUTICS INC (DNLI) has been bought by David M. Polen - Polen Capital Management (added shares +142.75%).

To see more about who is investing in DENALI THERAPEUTICS INC (DNLI), please go to the DNLI ownership page.

2026 Q1 (1 result)
David M. Polen
+142.75%
+38,401
+0.01%
0.01%
Current price: $19.66 2.40% Reported price*: $19.20
2025 Q4 (1 result)
David M. Polen
buy
+26,900
+0.00%
0.00%
Current price: $19.66 19.08% Reported price*: $16.51
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.